Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022

We describe persistent circulation of SARS-CoV-2 Alpha variant in an immunosuppressed patient in France during February 2022. The virus had a new pattern of mutation accumulation. The ongoing circulation of previous variants of concern could lead to reemergence of variants with the potential to prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourati, Slim, Gautier, Guillaume, Chovelon, Myriam, Soulier, Alexandre, N’Debi, Melissa, Demontant, Vanessa, Kennel, Céline, Rodriguez, Christophe, Pawlotsky, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239896/
https://www.ncbi.nlm.nih.gov/pubmed/35514025
http://dx.doi.org/10.3201/eid2807.220467
_version_ 1784737413896077312
author Fourati, Slim
Gautier, Guillaume
Chovelon, Myriam
Soulier, Alexandre
N’Debi, Melissa
Demontant, Vanessa
Kennel, Céline
Rodriguez, Christophe
Pawlotsky, Jean-Michel
author_facet Fourati, Slim
Gautier, Guillaume
Chovelon, Myriam
Soulier, Alexandre
N’Debi, Melissa
Demontant, Vanessa
Kennel, Céline
Rodriguez, Christophe
Pawlotsky, Jean-Michel
author_sort Fourati, Slim
collection PubMed
description We describe persistent circulation of SARS-CoV-2 Alpha variant in an immunosuppressed patient in France during February 2022. The virus had a new pattern of mutation accumulation. The ongoing circulation of previous variants of concern could lead to reemergence of variants with the potential to propagate future waves of infection.
format Online
Article
Text
id pubmed-9239896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-92398962022-07-06 Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022 Fourati, Slim Gautier, Guillaume Chovelon, Myriam Soulier, Alexandre N’Debi, Melissa Demontant, Vanessa Kennel, Céline Rodriguez, Christophe Pawlotsky, Jean-Michel Emerg Infect Dis Research Letter We describe persistent circulation of SARS-CoV-2 Alpha variant in an immunosuppressed patient in France during February 2022. The virus had a new pattern of mutation accumulation. The ongoing circulation of previous variants of concern could lead to reemergence of variants with the potential to propagate future waves of infection. Centers for Disease Control and Prevention 2022-07 /pmc/articles/PMC9239896/ /pubmed/35514025 http://dx.doi.org/10.3201/eid2807.220467 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Fourati, Slim
Gautier, Guillaume
Chovelon, Myriam
Soulier, Alexandre
N’Debi, Melissa
Demontant, Vanessa
Kennel, Céline
Rodriguez, Christophe
Pawlotsky, Jean-Michel
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title_full Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title_fullStr Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title_full_unstemmed Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title_short Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022
title_sort persistent sars-cov-2 alpha variant infection in immunosuppressed patient, france, february 2022
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239896/
https://www.ncbi.nlm.nih.gov/pubmed/35514025
http://dx.doi.org/10.3201/eid2807.220467
work_keys_str_mv AT fouratislim persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT gautierguillaume persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT chovelonmyriam persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT soulieralexandre persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT ndebimelissa persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT demontantvanessa persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT kennelceline persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT rodriguezchristophe persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022
AT pawlotskyjeanmichel persistentsarscov2alphavariantinfectioninimmunosuppressedpatientfrancefebruary2022

Ejemplares similares